SCHEMBL27084816

SCHEMBL27084816

C=CCN(C)CCc1c[nH]c2ccc(OC3OC(CO)C(O)C(O)C3O)cc12

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTR1D P28221 5/20 0.49
▸ HTR1A P08908 4/20 0.49
▸ HTR1B P28222 4/20 0.49
▸ HTR2A P28223 4/20 0.49
▸ HTR2C P28335 4/20 0.49
▸ HTR1E P28566 4/20 0.49
▸ HTR7 P34969 4/20 0.49
▸ HTR2B P41595 4/20 0.49
▸ HTR5A P47898 4/20 0.49
▸ HTR6 P50406 4/20 0.49
▸ ADRA2A P08913 3/20 0.49
▸ ADRA2B P18089 3/20 0.49
▸ ADRA2C P18825 3/20 0.49
▸ SLC6A4 P31645 3/20 0.49
▸ HRH1 P35367 3/20 0.49
▸ DRD3 P35462 3/20 0.49
▸ OPRK1 P41145 3/20 0.49
▸ SLC6A3 Q01959 3/20 0.49
▸ SIGMAR1 Q99720 3/20 0.49
▸ SLC6A2 P23975 2/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27085082 0.93 TYR (0.47) HTR6ATMSLC5A2SLC5A1TYR
SCHEMBL27084692 0.91 HTR1A (0.58) HTR1DHTR1AHTR1BHTR2AHTR2C
SCHEMBL27084802 0.90 HTR1D (0.55) HTR1DHTR1AHTR1BHTR2AHTR2C
SCHEMBL27085230 0.89 HTR1D (0.51) HTR1DHTR1AHTR1BHTR2AHTR2C
SCHEMBL27085283 0.89 HTR2A (0.52) HTR1DHTR1AHTR1BHTR2AHTR2C
SCHEMBL26790992 0.88 HTR1D (0.56) HTR1DHTR1AHTR1BHTR2AHTR2C
SCHEMBL27084741 0.88 HTR1D (0.56) HTR1DHTR1AHTR1BHTR2AHTR2C
SCHEMBL26790014 0.88 HTR1D (0.56) HTR1DHTR1AHTR1BHTR2AHTR2C
SCHEMBL27084910 0.85 ATM (0.48) HTR1DHTR1AHTR1BHTR2AHTR2C
SCHEMBL27084663 0.84 HTR1A (0.57) HTR1DHTR1AHTR1BHTR2AATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240043382-A1 MODIFIED INDOLE ALKALOIDS FOR THERAPEUTIC USES COMPASS PATHFINDER LIMITED (GB) 2024-02-08 — — US disclosed
CN-117120415-A Modified indole alkaloids for therapeutic use 指南针探路者有限公司 2023-11-24 — — CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240043382-A1 MODIFIED INDOLE ALKALOIDS FOR THERAPEUTIC USES INMT, AANAT, HNMT HTR1D 664/4885HTR1A 181/4885HTR1B 324/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback